Junning Lee - Net Worth and Insider Trading
Junning Lee Net Worth
The estimated net worth of Junning Lee is at least $2 Million dollars as of 2024-04-19. Junning Lee is the Sr. VP, Technical Operations of Theravance Biopharma Inc and owns about 178,720 shares of Theravance Biopharma Inc (TBPH) stock worth over $2 Million. Details can be seen in Junning Lee's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Junning Lee has not made any transactions after 2015-08-18 and currently still holds the listed stock(s).
Transaction Summary of Junning Lee
Junning Lee Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Junning Lee owns 2 companies in total, including Theravance Biopharma Inc () , and Innoviva Inc () .
Click here to see the complete history of Junning Lee’s form 4 insider trades.
Insider Ownership Summary of Junning Lee
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| Theravance Biopharma Inc | 2015-08-18 | Sr. VP & Technical Operations | |
| Innoviva Inc | 2014-01-06 | Sr. VP & Technical Operations |
Junning Lee Latest Holdings Summary
Junning Lee currently owns a total of 1 stock. Junning Lee owns 178,720 shares of Theravance Biopharma Inc (TBPH) as of August 18, 2015, with a value of $2 Million.
Latest Holdings of Junning Lee
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TBPH | Theravance Biopharma Inc | 2015-08-18 | 178,720 | 9.21 | 1,646,011 |
Holding Weightings of Junning Lee
Junning Lee Form 4 Trading Tracker
According to the SEC Form 4 filings, Junning Lee has made a total of 0 transactions in Theravance Biopharma Inc (TBPH) over the past 5 years. The most-recent trade in Theravance Biopharma Inc is the acquisition of 9,000 shares on August 18, 2015, which cost Junning Lee around $116,100.
Insider Trading History of Junning Lee
- 1
Junning Lee Trading Performance
GuruFocus tracks the stock performance after each of Junning Lee's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Junning Lee is 36.98%. GuruFocus also compares Junning Lee's trading performance to market benchmark return within the same time period. The performance of stocks bought by Junning Lee within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Junning Lee's insider trading performs compared to the benchmark.
Performance of Junning Lee
Average Return
122.34%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.47 | 36.98 | 21.19 | 122.34 | 46.29 | 28.53 |
| Relative Return to S&P 500(%) | 12.09 | 37.62 | 29.73 | 118.06 | 38.75 | 17.76 |
Junning Lee Ownership Network
Ownership Network List of Junning Lee
Ownership Network Relation of Junning Lee
Junning Lee Owned Company Details
What does Theravance Biopharma Inc do?
Who are the key executives at Theravance Biopharma Inc?
Junning Lee is the Sr. VP & Technical Operations of Theravance Biopharma Inc. Other key executives at Theravance Biopharma Inc include SVP & Comm & Medical Affairs Rhonda Farnum , SVP & Development Richard A Graham , and SVP & Gen Counsel and Secretary Brett A. Grimaud .
Theravance Biopharma Inc () Insider Trades Summary
Over the past 18 months, Junning Lee made no insider transaction in Theravance Biopharma Inc (). Other recent insider transactions involving Theravance Biopharma Inc () include a net sale of 25,787 shares made by Richard A Graham , a net sale of 10,229 shares made by Rhonda Farnum , and a net sale of 65,000 shares made by Andrew A. Hindman .
In summary, during the past 3 months, insiders sold 1,254 shares of Theravance Biopharma Inc () in total and bought 0 shares, with a net sale of 1,254 shares. During the past 18 months, 151,016 shares of Theravance Biopharma Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 151,016 shares.
Theravance Biopharma Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Theravance Biopharma Inc Insider Transactions
Junning Lee Mailing Address
Above is the net worth, insider trading, and ownership report for Junning Lee. You might contact Junning Lee via mailing address: 901 Gateway Blvd, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
